findmyKOL
Clinical trialNCT02166476CompletedPhase 3Interventional

Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP

SponsorMelinta Therapeutics, Inc.Enrollment550Acute PyelonephritisUrinary Tract Infection Complicated
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

77 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belarus
  • Facility name not stated

    Brest, Belarus

  • Facility name not stated

    Grodno, Belarus

  • Facility name not stated

    Homyel, Belarus

  • Facility name not stated

    Minsk, Belarus

  • Facility name not stated

    Minsk, Belarus

  • Facility name not stated

    Vitebsk, Belarus

Brazil
  • Facility name not stated

    São José do Rio Preto, São Paulo, Brazil

  • Facility name not stated

    Belo Horizonte, Brazil

  • Facility name not stated

    Belo Horizonte, Brazil

  • Facility name not stated

    Campinas, Brazil

  • Facility name not stated

    Rio de Janeiro, Brazil

  • Facility name not stated

    São Paulo, Brazil

Bulgaria
  • Facility name not stated

    Lovech, Bulgaria

  • Facility name not stated

    Montana, Bulgaria

  • Facility name not stated

    Silistra, Bulgaria

  • Facility name not stated

    Sofia, Bulgaria

  • Facility name not stated

    Sofia, Bulgaria

  • Facility name not stated

    Varna, Bulgaria

Czechia
  • Facility name not stated

    Hradec Králové, Czechia

  • Facility name not stated

    Karlovy Vary, Czechia

  • Facility name not stated

    Opava, Czechia

  • Facility name not stated

    Zlín, Czechia

  • Facility name not stated

    Ústí nad Labem, Czechia

Greece
  • Facility name not stated

    Athens, Greece

  • Facility name not stated

    Athens, Greece

  • Facility name not stated

    Athens, Greece

  • Facility name not stated

    Athens, Greece

  • Facility name not stated

    Thessaloniki, Greece

Hungary
  • Facility name not stated

    Baja, Hungary

  • Facility name not stated

    Budapest, Hungary

  • Facility name not stated

    Debrecen, Hungary

  • Facility name not stated

    Sopron, Hungary

Italy
  • Facility name not stated

    Bologna, Italy

  • Facility name not stated

    Catania, Italy

  • Facility name not stated

    Florence, Italy

  • Facility name not stated

    Perugia, Italy

  • Facility name not stated

    Torino, Italy

Peru
  • Facility name not stated

    Arequipa, Peru

  • Facility name not stated

    Cusco, Peru

  • Facility name not stated

    Ica, Peru

37 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Nov 2014
Primary completion
28 Apr 2016
Completion
28 Apr 2016
Last update posted
11 Jun 2018
Registered enrollment
550
Registry id
NCT02166476
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.